cbdMD Inc Net Income
| YCBD Stock | USD 0.78 0.08 11.43% |
As of the 17th of February 2026, CbdMD shows the Risk Adjusted Performance of 0.0491, semi deviation of 7.91, and Mean Deviation of 8.99. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of CbdMD, as well as the relationship between them. Please confirm cbdMD Inc variance and the relationship between the treynor ratio and expected short fall to decide if cbdMD Inc is priced correctly, providing market reflects its regular price of 0.78 per share. As cbdMD Inc is a penny stock we also strongly suggest to validate its total risk alpha numbers.
CbdMD Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.3063 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -66.7 M | -63.3 M | |
| Net Loss | -1.8 B | -1.7 B | |
| Net Loss | -1.8 M | -1.9 M | |
| Net Loss | (0.46) | (0.48) | |
| Net Income Per E B T | 0.95 | 1.00 |
CbdMD | Net Income | Build AI portfolio with CbdMD Stock |
Analyzing CbdMD's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing CbdMD's current valuation and future prospects.
Latest CbdMD's Net Income Growth Pattern
Below is the plot of the Net Income of cbdMD Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in cbdMD Inc financial statement analysis. It represents the amount of money remaining after all of cbdMD Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CbdMD's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CbdMD's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (2.04 B) | 10 Years Trend |
|
Net Income |
| Timeline |
CbdMD Net Income Regression Statistics
| Arithmetic Mean | (10,230,255) | |
| Geometric Mean | 3,588,092 | |
| Coefficient Of Variation | (205.21) | |
| Mean Deviation | 14,697,359 | |
| Median | (1,836,812) | |
| Standard Deviation | 20,993,257 | |
| Sample Variance | 440.7T | |
| Range | 86.7M | |
| R-Value | (0.21) | |
| Mean Square Error | 449T | |
| R-Squared | 0.04 | |
| Significance | 0.41 | |
| Slope | (880,750) | |
| Total Sum of Squares | 7051.5T |
CbdMD Net Income History
Other Fundumenentals of cbdMD Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
CbdMD Net Income component correlations
CbdMD Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for CbdMD is extremely important. It helps to project a fair market value of CbdMD Stock properly, considering its historical fundamentals such as Net Income. Since CbdMD's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CbdMD's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CbdMD's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Pharmaceuticals sector continue expanding? Could CbdMD diversify its offerings? Factors like these will boost the valuation of CbdMD. Anticipated expansion of CbdMD directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CbdMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.51 | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
cbdMD Inc's market price often diverges from its book value, the accounting figure shown on CbdMD's balance sheet. Smart investors calculate CbdMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CbdMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CbdMD 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CbdMD's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CbdMD.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in CbdMD on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding cbdMD Inc or generate 0.0% return on investment in CbdMD over 90 days. CbdMD is related to or competes with Biofrontera, Evoke Pharma, Sunshine Biopharma, Sonoma Pharmaceuticals, Meihua International, Neurosense Therapeutics, and STRATA Skin. cbdMD, Inc. produces and distributes various cannabidiol products More
CbdMD Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CbdMD's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess cbdMD Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.68 | |||
| Information Ratio | 0.0448 | |||
| Maximum Drawdown | 112.24 | |||
| Value At Risk | (14.98) | |||
| Potential Upside | 21.17 |
CbdMD Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CbdMD's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CbdMD's standard deviation. In reality, there are many statistical measures that can use CbdMD historical prices to predict the future CbdMD's volatility.| Risk Adjusted Performance | 0.0491 | |||
| Jensen Alpha | 0.8796 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0838 | |||
| Treynor Ratio | (0.51) |
CbdMD February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0491 | |||
| Market Risk Adjusted Performance | (0.50) | |||
| Mean Deviation | 8.99 | |||
| Semi Deviation | 7.91 | |||
| Downside Deviation | 8.68 | |||
| Coefficient Of Variation | 2037.31 | |||
| Standard Deviation | 16.24 | |||
| Variance | 263.88 | |||
| Information Ratio | 0.0448 | |||
| Jensen Alpha | 0.8796 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0838 | |||
| Treynor Ratio | (0.51) | |||
| Maximum Drawdown | 112.24 | |||
| Value At Risk | (14.98) | |||
| Potential Upside | 21.17 | |||
| Downside Variance | 75.31 | |||
| Semi Variance | 62.52 | |||
| Expected Short fall | (14.92) | |||
| Skewness | 3.45 | |||
| Kurtosis | 15.86 |
cbdMD Inc Backtested Returns
CbdMD is out of control given 3 months investment horizon. cbdMD Inc secures Sharpe Ratio (or Efficiency) of 0.0909, which signifies that the company had a 0.0909 % return per unit of standard deviation over the last 3 months. We have analyzed twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.53% are justified by taking the suggested risk. Use CbdMD Semi Deviation of 7.91, mean deviation of 8.99, and Risk Adjusted Performance of 0.0491 to evaluate company specific risk that cannot be diversified away. CbdMD holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.54, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning CbdMD are expected to decrease by larger amounts. On the other hand, during market turmoil, CbdMD is expected to outperform it. Use CbdMD jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on CbdMD.
Auto-correlation | -0.4 |
Poor reverse predictability
cbdMD Inc has poor reverse predictability. Overlapping area represents the amount of predictability between CbdMD time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of cbdMD Inc price movement. The serial correlation of -0.4 indicates that just about 40.0% of current CbdMD price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
CbdMD Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, cbdMD Inc reported net income of (2.04 Billion). This is 698.01% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is significantly higher than that of the company.
CbdMD Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CbdMD's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CbdMD could also be used in its relative valuation, which is a method of valuing CbdMD by comparing valuation metrics of similar companies.CbdMD is currently under evaluation in net income category among its peers.
CbdMD Current Valuation Drivers
We derive many important indicators used in calculating different scores of CbdMD from analyzing CbdMD's financial statements. These drivers represent accounts that assess CbdMD's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of CbdMD's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 107.6M | 16.7M | 16.2M | 4.9M | 5.6M | 5.3M | |
| Enterprise Value | 105.8M | 18.5M | 15.0M | 780.8M | 898.0M | 942.9M |
CbdMD Fundamentals
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.0944 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 5.88 M | ||||
| Shares Outstanding | 8.91 M | ||||
| Shares Owned By Insiders | 16.00 % | ||||
| Shares Owned By Institutions | 5.63 % | ||||
| Number Of Shares Shorted | 229.56 K | ||||
| Price To Earning | 17.62 X | ||||
| Price To Book | 1.02 X | ||||
| Price To Sales | 0.38 X | ||||
| Revenue | 19.19 M | ||||
| Gross Profit | 11.64 M | ||||
| EBITDA | (244.98 K) | ||||
| Net Income | (2.04 B) | ||||
| Cash And Equivalents | 10.55 M | ||||
| Cash Per Share | 0.17 X | ||||
| Total Debt | 778.24 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 3.47 X | ||||
| Book Value Per Share | 0.69 X | ||||
| Cash Flow From Operations | (1.45 M) | ||||
| Short Ratio | 0.19 X | ||||
| Earnings Per Share | 0.51 X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 42 | ||||
| Beta | 2.21 | ||||
| Market Capitalization | 6.58 M | ||||
| Total Asset | 10.42 M | ||||
| Retained Earnings | (179.44 B) | ||||
| Working Capital | 3.36 M | ||||
| Net Asset | 10.42 M |
About CbdMD Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze cbdMD Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CbdMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of cbdMD Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:Check out You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Will Pharmaceuticals sector continue expanding? Could CbdMD diversify its offerings? Factors like these will boost the valuation of CbdMD. Anticipated expansion of CbdMD directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CbdMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.51 | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
cbdMD Inc's market price often diverges from its book value, the accounting figure shown on CbdMD's balance sheet. Smart investors calculate CbdMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CbdMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.